Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 13.619.5710.398.086.35

What is the latest Price to Cash Earnings (PCE) ratio of AUROBINDO PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of AUROBINDO PHARMA is 13.61 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202413.61
Mar20239.57
Mar202210.39
Mar20218.08
Mar20206.35

How is Price to Cash Earnings (PCE) of AUROBINDO PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 13.61
42.22
Mar2023 9.57
-7.89
Mar2022 10.39
28.59
Mar2021 8.08
27.24
Mar2020 6.35 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses